Fundraising Fox

Vantis Vascular

San Jose, US · Founded 2018 · Delaware corporation

Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose

HardwareHealthtechMedical Devices

Founders & leadership

GMGary McCord
Gary McCordinExecutive
MMMarc Monahan
Marc MonahaninExecutive
MMMike Mirizzi
Mike MirizziinExecutive
JTJason Turner
Jason TurnerinExecutive
FSFrank Saltiel
Frank SaltielinExecutive
TFTim Fischell
Tim FischellinNamed on SEC filing

Board

LP
Len PinchukBoard director

Funding

SEC filings, press & company announcements

$46.7M disclosed across 7 rounds · 2018–2026

▶$18.6MraisedJul 2026 · 123 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim FischellExecutive Officer, Director
  • Frank SaltielExecutive Officer, Director
  • Len PinchukDirector
  • Jason TurnerExecutive Officer, Director
  • Marc MonahanExecutive Officer
  • Mike MirizziExecutive Officer
  • Gary McCordExecutive Officer
Offering amount
$21.5M
Amount sold
$18.6M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.3MraisedOct 2024 · 114 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Len PinchukDirector
  • Gary McCordExecutive Officer
  • Tim FischellExecutive Officer, Director
  • Marc MonahanExecutive Officer
  • Mike MirizziExecutive Officer
  • Jason TurnerExecutive Officer, Director
  • Frank SaltielExecutive Officer, Director
Offering amount
$22.2M
Amount sold
$14.3M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedFeb 2022 · 73 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SaltielExecutive Officer, Director
  • Jason TurnerExecutive Officer, Director
  • Len PinchukDirector
  • Tim FischellExecutive Officer, Director
Offering amount
$8M
Amount sold
$7M
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$503.5KraisedSep 2021 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SaltielExecutive Officer, Director
  • Tim FischellExecutive Officer, Director
  • Len PinchukDirector
Offering amount
$800K
Amount sold
$503.5K
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$700KraisedDec 2020 · 20 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Len PinchukDirector
  • Frank SaltielExecutive Officer, Director
  • Tim FischellExecutive Officer, Director
Offering amount
$1M
Amount sold
$700K
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$485KraisedDec 2018 · 14 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim FischellExecutive Officer, Director
  • Frank SaltielExecutive Officer, Director
  • Len PinchukDirector
Offering amount
$1.8M
Amount sold
$485K
Minimum investment
$25K
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Boston Scientific43 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf Surgical41 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Innova Vascular29 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
AngioDynamics27 shared keywordsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.
Bioworld22 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Vantis Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Vantis Vascular has filed a notice of an exempt offering of securities to raise $21,500,000.00 in New Funding. - intelligence360intelligence360.news · Aug 2026Vantis Vascular Secures Funding for CrossFast Microcatheter Delivery System Commercialization - Cardiac Interventions Todaycitoday.com · Dec 2024VANTIS VASCULAR CLOSES $10M IN SERIES B-1 PREFERRED FINANCINGprnewswire.com · Dec 2024Vantis Vascular secures funding to advance intervention technologiesfinance.yahoo.com · May 2024Vantis Vascular raises $5M for microcatheter, IVL systemmedicaltubingandextrusion.com · May 2024

Frequently asked questions

What does Vantis Vascular do?
Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose
How much funding has Vantis Vascular raised?
Vantis Vascular has disclosed $46.7M raised across 7 rounds.
Where is Vantis Vascular headquartered?
Vantis Vascular is headquartered in San Jose, US.